SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Certuity LLC

Certuity LLC increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.8% during the 4th quarter, Holdings Channel reports. The fund owned 11,168 shares of the exchange traded fund’s stock after purchasing an additional 2,494 shares during the quarter. Certuity LLC’s holdings in SPDR S&P Biotech ETF were worth $1,006,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Hartline Investment Corp increased its holdings in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after buying an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock valued at $231,000 after buying an additional 125 shares during the last quarter. Denver Wealth Management Inc. grew its holdings in shares of SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after purchasing an additional 127 shares during the last quarter. Trust Co. of Vermont boosted its stake in shares of SPDR S&P Biotech ETF by 4.7% during the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after buying an additional 138 shares during the period. Finally, Graypoint LLC boosted its stake in shares of SPDR S&P Biotech ETF by 5.6% during the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after buying an additional 146 shares during the period.

SPDR S&P Biotech ETF Stock Down 1.4 %

Shares of NYSEARCA:XBI opened at $89.05 on Wednesday. The company has a 50-day moving average price of $92.23 and a 200 day moving average price of $96.30. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The company has a market cap of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.